Informations éducatives uniquement. Les utilisations expérimentales peuvent ne pas avoir l'approbation de la FDA. Pas un avis médical ou un plan de traitement.
Pinealon is a synthetic tripeptide (Glu-Asp-Arg) developed as part of a series of short peptide bioregulators studied by Russian researchers, primarily in the context of aging and neuroprotection. It is thought to have an affinity for neuronal cell nuclei and is studied in preclinical settings for its potential neuroprotective and neurorestorative signaling properties, with particular interest in its possible interactions with pineal gland function and circadian-related pathways.
Domaines de recherche
Neuroprotective Signaling ResearchPreclinical studies investigate Pinealon's potential to protect neurons from oxidative stress-induced apoptotic signaling, exploring its effects on anti-apoptotic pathway regulation and neuronal survival signaling research.
Neuronal Aging & Longevity ResearchStudies explore its effects on markers of neuronal aging in animal models, including research on oxidative DNA damage signaling, protein homeostasis pathways, and age-related neurodegeneration-related signaling research.
Cognitive & Neurorestorative Pathway ResearchResearchers investigate Pinealon's effects on cognitive function-related signaling in aging animal models, exploring its potential influence on learning and memory pathway research and neuroplasticity signaling.